Clinical trial
A Multicenter, Double-blind, Crossover Design, Pilot Study to Evaluate the Effect of NVC-422 Catheter Irrigation on Urinary Catheter Patency
NCT01243125 is registered in ClinicalTrials.gov with NovaBay Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double-blind, Crossover Design, Pilot Study to Evaluate the Effect of NVC-422 Catheter Irrigation on Urinary Catheter Patency
- Lead sponsor
- NovaBay Pharmaceuticals, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- August 31, 2013
- Enrollment
- 67 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
urinary catheter blockage and encrustation